title: Erratum: Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian carcinoma during the drug shortage era [Corrigendum].
abstract: [This corrects the article on p. 1409 in vol. 7, PMID: 25143745.].